Efficacy of contraceptive methods: A review of the literature

被引:102
作者
Mansour, Diana [1 ]
Inki, Pirjo [2 ]
Gemzell-Danielsson, Kristina [3 ]
机构
[1] Newcastle Sexual Hlth Serv, New Croft Ctr, Newcastle Upon Tyne NE1 6ND, Tyne & Wear, England
[2] Bayer Schering Pharma AG, Berlin, Germany
[3] Karolinska Inst, WHO Ctr, Dept Woman & Child Hlth, Div Obstet & Gynaecol, Stockholm, Sweden
关键词
30; MU-G; G ETHINYL ESTRADIOL; COMBINED ORAL-CONTRACEPTIVES; COMPARATIVE CLINICAL-TRIAL; ONCE-A-MONTH; LATIN-AMERICAN EXPERIENCE; HEALTH RESEARCH NETWORK; CYCLE CONTROL; G DESOGESTREL; VAGINAL RING;
D O I
10.3109/13625180903427675
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Methods Medline and Embase were searched using the Ovid interface from January 1990 to February 2008, as well as the reference lists of published articles, to identify studies reporting contraceptive efficacy as a Pearl Index or life-table estimate. Reports that recruited less than 400 subjects per study group and those covering less than six cycles/six months were excluded. In addition, unlicensed products or those not internationally available, emergency contraception, and vasectomy studies were excluded. Results Information was identified and extracted from 139 studies. One-year Pearl Indices reported for short-acting user-dependent hormonal methods were generally less than 2.5. Gross life-table rates for long-acting hormonal methods (implants and the levonorgestrel releasing-intrauterine system [LNG-IUS]) generally ranged between 0-0.6 per 100 at one year, but wider ranges (0.1-1.5 per 100) were observed for the copper intrauterine devices (0.1-1.4 per 100 for Cu-IUDs with surface area >= 300 mm<SU2</SU and 0.6-1.5 per 100 for those with surface area < 300 mm<SU2</SU). Barrier and natural methods were the least effective. Conclusions Our review broadly confirms the hierarchy of contraceptive effectiveness in descending order as: (1) female sterilisation, long-acting hormonal contraceptives (LNG-IUS and implants); (2) Cu-IUDs with >= 300 mm<SU2</SU surface area; (3) Cu-IUDs with < 300 mm<SU2</SU surface area and short-acting hormonal contraceptives (injectables, oral contraceptives, the patch and vaginal ring), and (4) barrier methods and natural methods.
引用
收藏
页码:4 / 16
页数:13
相关论文
共 155 条
[1]   Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 μg of ethinyl estradiol and 3 mg of drospirenone [J].
Ahrendt, Hans-Joachim ;
Nisand, Israel ;
Bastianelli, Carlo ;
Gomez, Maria Angeles ;
Gemzell-Danielsson, Kristina ;
Urdl, Wolfgang ;
Karskov, Birgit ;
Oeyen, Luc ;
Bitzer, Johannes ;
Page, Geert ;
Milsom, Ian .
CONTRACEPTION, 2006, 74 (06) :451-457
[2]   COMPARATIVE PROFILES OF RELIABILITY, CYCLE CONTROL AND SIDE-EFFECTS OF 2 OR AL CONTRACEPTIVE FORMULATIONS CONTAINING 150 MU-G DESOGESTREL AND EITHER 30 MU-G OR 20 MU-G ETHINYL ESTRADIOL [J].
AKERLUND, M ;
RODE, A ;
WESTERGAARD, J .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (09) :832-838
[3]   A 5-YEAR CLINICAL-EVALUATION OF NORPLANT(R) CONTRACEPTIVE SUBDERMAL IMPLANTS IN BANGLADESHI ACCEPTORS [J].
AKHTER, H ;
DUNSON, TR ;
AMATYA, RN ;
BEGUM, K ;
CHOWDHURY, T ;
DIGHE, N ;
KRUEGER, SL ;
RAHMAN, S .
CONTRACEPTION, 1993, 47 (06) :569-582
[4]  
Akin M, 1998, AM J OBSTET GYNECOL, V179, pS2
[5]   Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol [J].
Anderson, FD ;
Gibbons, W ;
Portman, D .
CONTRACEPTION, 2006, 73 (03) :229-234
[6]   LEVONORGESTREL-RELEASING AND COPPER-RELEASING (NOVA T) IUDS DURING 5 YEARS OF USE - A RANDOMIZED COMPARATIVE TRIAL [J].
ANDERSSON, K ;
ODLIND, V ;
RYBO, G .
CONTRACEPTION, 1994, 49 (01) :56-72
[7]  
[Anonymous], 1998, Eur J Contracept Reprod Health Care, V3, P169
[8]  
[Anonymous], 1994, Contraception, V49, P543
[9]  
[Anonymous], 1999, Eur J Contracept Reprod Health Care, V4 Suppl 2, P9
[10]  
[Anonymous], 1999, Eur J Contracept Reprod Health Care, V4 Suppl 2, P17